![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW PSYCHOCUTANEOUS DISEASES
Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4):549-56
DOI: 10.23736/S0392-0488.18.05978-3
Copyright © 2018 EDIZIONI MINERVA MEDICA
language: English
Psychopharmacology
Sahil SEKHON 1, George KROUMPOUZOS 2, 3, John KOO 1 ✉
1 Department of Dermatology, University of California, San Francisco, CA, USA; 2 Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, RI, USA; 3 Department of Dermatology, Medical School of Jundiaí, São Paulo, Brazil
Most dermatologists evaluate and treat patients with psychological or psychiatric issues related to their skin disease. These patients often require psychopharmacologic therapies. Therefore, it is important for dermatologists to be familiar with psychopharmacologic treatments for diseases that fit into the overlap between psychiatry and dermatology. This review aims to provide a concise overview of psychopharmacology as it applies to dermatology. Psychotropic medications commonly used in psychodermatology, including antidepressants, antipsychotics, and anxiolytics, are reviewed; safety profile and dosing recommendations are discussed.
KEY WORDS: Pharmaceutical preparations - Disease management - Antidepressive agents - Antipsychotic agents - Anti-anxiety agents